4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-031168
President and CEO gave up 3,510 shares (to pay taxes)
- President and CEO acquired 9,011 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2022-05-18 | Option exercise | +9,011 | 7,905,051 | D | ||
| Jiang Wenbin President and CEO | 2022-05-18 | Shares withheld for taxes | −3,510 | $9.65 | $33,872 | 7,901,541 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2022-05-18 | Option exercise · Restricted Stock Units | −9,011 | 99,126 | D | ||
Loading xslF345X03/doc4.xml…